Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Burris

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Seminars in Oncology|April 28, 2006
Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?Howard A Burris
HCA Healthcare Journal of Medicine|July 10, 2023
Research Amidst the PandemicHoward A Burris
The Oncologist|May 28, 2004
Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinibHoward A Burris
Cancer Chemotherapy and Pharmacology|February 5, 2013
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathwayHoward A Burris
Expert Opinion on Biological Therapy|April 22, 2011
Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancerHoward A Burris
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Trastuzumab Emtansine (T-DM1): Hitching a Ride on a Therapeutic AntibodyHoward A Burris
Expert Review of Anticancer Therapy|February 20, 2018
Ribociclib for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerHoward A Burris
Seminars in Oncology|September 7, 2005
Recent updates on the role of chemotherapy in pancreatic cancerHoward A Burris
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Developments in the use of antibody-drug conjugatesHoward A Burris
Seminars in Oncology|May 3, 2008
Preclinical investigations with epothilones in breast cancer modelsHoward A Burris
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Seminars in Oncology|April 28, 2006
Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?Howard A Burris
HCA Healthcare Journal of Medicine|July 10, 2023
Research Amidst the PandemicHoward A Burris
The Oncologist|May 28, 2004
Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinibHoward A Burris
Cancer Chemotherapy and Pharmacology|February 5, 2013
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathwayHoward A Burris
Expert Opinion on Biological Therapy|April 22, 2011
Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancerHoward A Burris
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Trastuzumab Emtansine (T-DM1): Hitching a Ride on a Therapeutic AntibodyHoward A Burris
Expert Review of Anticancer Therapy|February 20, 2018
Ribociclib for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerHoward A Burris
Seminars in Oncology|September 7, 2005
Recent updates on the role of chemotherapy in pancreatic cancerHoward A Burris
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Developments in the use of antibody-drug conjugatesHoward A Burris
Seminars in Oncology|May 3, 2008
Preclinical investigations with epothilones in breast cancer modelsHoward A Burris
Pageof 25